Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7482348
Reference Type
Journal Article
Title
Lung Cancer: Molecular Markers of Occupational Carcinogens
Author(s)
Nymark, PEH; Anttila, S; ,
Year
2020
Publisher
Springer International Publishing
Location
Cham
Book Title
Occupational Cancers
Page Numbers
227-238
Language
English
PMID
32875453
DOI
10.1007/978-3-030-30766-0_11
Web of Science Id
WOS:000565202100002
URL
http://link.springer.com/10.1007/978-3-030-30766-0_11
Exit
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are carcinogenic compounds which are emitted through incomplete combustion of organic materials, fossil fuels, consumption of processed meat, smoked food, and from various industrial activities. High molecular mass and mobility make PAHs widespread and lethal for human health. A cellular system in human detoxifies these toxicants through specialized enzymatic machinery called xenobiotic-metabolizing (CYP450) and phase-II (GSTs) enzymes (XMEs). These metabolizing enzymes include cytochromes P450 family (CYP1, CYP2), glutathione s-transferases, and ALDHs. Gene polymorphisms in XMEs encoding genes can compromise their metabolizing capacity to detoxify ingested carcinogens (PAHs etc.) that may lead to prolong and elevated exposure to ingested toxicants and may consequently lead to cancer. Moreover, PAHs can induce cancer through reprograming XMEs' gene functions by altering their epigenetic markers. This review article discusses possible interplay between individual's gene polymorphism in XMEs' genes, their altered epigenetic markers, and exposure to PAHs in cancer susceptibility in Pakistan.
Keywords
Asbestos; Biomarkers; Chromosomal aberrations; Epigenetic changes; Gene copy number profiling; Gene expression profiling; Genomics; Molecular markers; Occupational lung cancer
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity